Belgium leads the global biotechnology R&D intensity in the business sector with a value of 34.84%, registering a yearly increase of 1.61%. Lithuania (20.8%), the United States (17.91%), and Ireland (15.63%) show significant contributions, with Ireland experiencing the highest year-on-year growth at 7.82%. Germany's R&D intensity surged notably by 24.39%, but Poland and the Czech Republic experienced declines of 3.04% and 9.12%, respectively. While Latvia showed an outstanding increase of 34.12%, South Korea and Russia had modest improvements of 1.77% and 3.31%.
Future trends to watch include potential large-scale investments in countries with rapid growth rates like Latvia and Germany. Emerging economies with lower current intensity could also become significant contributors if strategic policies and investments are implemented, which can shift global dynamics towards more diversified biotechnology R&D efforts.
Top countries in Biotechnology R&D Intensity in the Business Sector by Country
| # | 10 Countries | Percent of BERD | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Belgium | 34.84 | 2023 | +0.85% | +1.61% | View data |
| 2 | 2 Lithuania | 20.8 | 2023 | +6.31% | +1.11% | View data |
| 3 | 3 United States | 17.91 | 2023 | +2.15% | +3.76% | View data |
| 4 | 4 Ireland | 15.63 | 2023 | -0.18% | +7.82% | View data |
| 5 | 5 Spain | 11.12 | 2023 | +2.95% | +4.07% | View data |
| 6 | 6 Estonia | 10.46 | 2023 | +0.14% | +3.86% | View data |
| 7 | 7 Canada | 5.15 | 2023 | +3.88% | +2.82% | View data |
| 8 | 8 Germany | 5.13 | 2023 | +14.26% | +24.39% | View data |
| 9 | 9 Italy | 3.8 | 2023 | +0.076% | +2.15% | View data |
| 10 | 10 Portugal | 3.46 | 2023 | +0.79% | +3.06% | View data |
